Apo-Indapamide

Maklumat utama

  • Nama dagangan:
  • Apo-Indapamide Tablet
  • Perubatan domain:
  • Manusia
  • Jenis perubatan:
  • Ubat Allopathic

Dokumen

Penyetempatan

  • Terdapat dalam:
  • Apo-Indapamide Tablet
    Malaysia
  • Bahasa:
  • Bahasa Melayu

Maklumat lain

Status

  • Sumber:
  • NPRA - National Pharmaceutical Regulatory Agency - Bahagian Regulatori Farmasi Negara
  • Nombor kebenaran:
  • MAL 1998696
  • Kemaskini terakhir:
  • 31-08-2017

Risalah Maklumat Pesakit: ciri produk - komposisi, petunjuk, kesan sampingan, dos, interaksi, tindak balas buruk, kehamilan, penyusuan

Risalah Maklumat Ubat untuk Pengguna (RiMUP)

APO-INDAPAMIDE TABLET

Indapamide (2.5mg)

Apakah yang ada pada risalah

ini

Apakah kegunaan Apo-

Indapamide

Bagaimana Apo-Indapamide

berfungsi

Sebelum menggunakan Apo-

Indapamide

Cara menggunakan Apo-

Indapamide

Semasa menggunakan Apo-

Indapamide

Kesan-kesan sampingan

Cara penyimpanan dan

pelupusan Apo-Indapamide

Maklumat lanjut

Pengilang dan Pemegang

Pendaftaran Produk

Tarikh kemaskini RiMUP

Apa kegunaan Apo-Indapamide

Indapamide tergolong dalam

kumpulan ubat yang dipanggil

diuretik ("pil air"). Ubat ini

diambil secara sendiri atau dengan

perubatan yang lain untuk

merawat tekanan darah tinggi.

Bagaimana Apo-Indapamide

berfungsi

Perubatan ini berfungsi untuk

menyahkan air dan garam

berlebihan daripada badan.

Sebelum menggunakan Apo-

Indapamide

-

Bila anda tidak boleh

menggunakan

Indapamide tidak boleh diambil

oleh mereka:

yang alah kepada perubatan

indapamide atau sulfa

sulfonamide

) (cth,

sulfamethoxazole

) atau

kepada sebarang bahan

kandungan di dalam ubat ini

yang tidak boleh membuang

yang berada dalam koma

hepatik (keadaan koma

disebabkan oleh penyakit hati

yang teruk)

mempunyai komplikasi

serebrovaskular (gangguan

peredaran darah ke otak)

-

Sebelum mula menggunakan

Apo-Indapamide

Beritahu doktor anda jika:

Anda menghidap kencing

manis.

Anda menghidap penyakit

gout, buah pinggang atau

hati.

Anda hamil, bercadang untuk

hamil, atau sedang menyusu

anak.

Jika mengambil ubat-ubat lain

Agen-agen berikut boleh

mempengaruhi keberkesanan

indapamide atau meningkatkan

risiko mendapat kesan sampingan:

alkohol

barbiturat

narkotik (cth, morfin)

perubatan yang merendahkan

tekanan darah

Indapamide boleh mempengaruhi

keberkesanan perubatan berikut

atau meningkatkan risiko

mendapat kesan sampingan:

digoxin

insulin

lithium

Cara menggunakan Apo-

Indapamide

-

Berapa banyak harus digunakan

Dos yang disyorkan untuk pesakit

dewasa ialah 2.5mg sekali sehari

pada waktu pagi. Jika jumlah dos

ini tidak dapat mengurangkan

tekanan darah tinggi anda, doktor

anda mungkin akan menambah

ubat penurunan tekanan darah

yang lain yang bukan diuretik

atau ubat diuretik yang lain.

Jangan melebihi dos harian

2.5 mg.

Bila perlu digunakan

Ikut arahan doktor atau ahli

farmasi anda.

- Berapa lama perlu digunakan

Jangan hentikan pengambilan

ubat ini tanpa merujuk kepada

doktor anda terlebih dahulu.

Penghentian secara tiba-tiba boleh

menyebabkan keadaan anda

menjadi lebih teruk.

Jika terlupa menggunakan

Ambil dos yang tertinggal sebaik

sahaja anda teringat semula.

Jika sudah hampir masa untuk

pengambilan dos seterusnya, anda

tidak perlu ambil dos yang sudah

terlepas. Hanya ambil dos yang

seterusnya pada waktu yang

ditetapkan. Jangan ambil dos

berganda.

Jika mengambil berlebihan

(terlebih dos)

Jika terlebih dos, dalam semua

kes, rawatan ini perlu dihentikan

dan anda perlu menghubungi

doktor anda atau pergi ke

bahagian kecemasan pada hospital

yang berdekatan dengan segera.

Semasa menggunakan Apo-

Indapamide

Perkara yang perlu dilakukan

Ambil ubat anda mengikut arahan

doktor.

Maklumkan kepada semua doktor,

doktor gigi dan ahli farmasi yang

merawat anda bahawa anda

Risalah Maklumat Ubat untuk Pengguna (RiMUP)

sedang menggunakan Apo-

Indapamide.

Beritahu doktor anda dengan

segera jika anda menjadi hamil

semasa menggunakan ubat ini.

Perkara yang tidak boleh

dilakukan

Jangan berhenti menggunakan

ubat ini kecuali diarahkan oleh

doktor anda.

Jangan mula mengambil sebarang

ubat baru tanpa berbincang

dengan doktor atau ahli farmasi

anda.

Jangan berkongsi Apo-

Indapamide dengan sesiapa,

walaupun mereka mempunyai

simptom atau penyakit yang

sama.

Perkara yang perlu diberi

perhatian

Memandu dan menggunakan

jentera

Ubat ini mungkin mengganggu

keupayaan anda untuk memandu

atau mengendalikan jentera, Jika

ubat ini menyebabkan anda terasa

loya, pening, letih, atau sakit

kepala, jangan memandu atau

mengendalikan jentera dan

hubungi doktor anda dengan

segera.

Kesan-kesan sampingan

Kesan sampingan berikut akan

hilang setelah badan anda menjadi

biasa dengan ubat ini; rujuk

kepada doktor anda sekiranya

kesan sampingan ini berlanjutan

atau memberi gangguan.

Kesan sampingan yang paling

ketara dan biasa daripada ubat ini

termasuk

hypokalemia

(tahap

kalium rendah dalam badan),

hypochloremia

(tahap ion klorida

yang rendah dalam badan),

hyponatremia

(tahap garam

rendah). Kesan sampingan yang

lain mungkin termasuk perasaan

mengantuk, kesukaran tidur, loya,

muntah, kekejangan otot,

tachycardia

(kadar jantung

tinggi), ruam.

Senarai ini tidak mengandungi

kesan sampingan yang lengkap

dan kesan lain juga mungkin

berlaku. Beritahu doktor anda

tentang sebarang kesan

sampingan yang luar biasa atau

mengganggu.

Anda boleh melaporkan sebarang

kesan sampingan atau kesan

advers ubat kepada Pusat

Pemantauan Kesan Advers Ubat

Kebangsaan melalui No. Tel: 03-

78835550, atau laman web

portal.bpfk.gov.my

Consumers

Reporting

Cara penyimpanan dan

pelupusan Apo-Indapamide

-

Penyimpanan

Anda diingatkan supaya

menyimpan APO-

INDAPAMIDE. dan semua ubat-

ubat lain jauh daripada kanak-

kanak.

Jangan gunakan ubat ini selepas

tarikh luput yang tertera pada

bekas ini.

Simpan APO-INDAPAMIDE

pada suhu bilik (bawah 30°C).

Simpan dalam bekas tertutup.

-

Pelupusan

Sekiranya anda masih mempunyai

lebihan ubat ini selepas anda

hentikan pengambilannya atas

arahan doktor atau kerana anda

dapati ubat ini telah melepasi

tarikh luputnya, sila rujuk kepada

ahli farmasi anda tentang langkah

yang perlu diambil.

Maklumat Lanjut

-

Rupa dan warna produk

Warna merah jambu, berbentuk

bulat, dwicembung, bersalut

filem, berukir “2.5” pada satu

permukaan dan kosong pada satu

lagi, mengandungi 2.5mg

indapamide.

-

Bahan- bahan Kandungan

- Bahan aktif: Indapamide

- Bahan tidak aktif:

Anhydrous

lactose, magnesium stearate,

croscarmellose sodium,

hydroxyethyl cellulose,

polyethylene glycol, titanium

dioxide, D&C Red #30 Aluminium

Lake 30%

Purified Water.

-

Nombor MAL

MAL 19986967A

Pengilang

Apotex Inc.

150 Signet Drive

Weston Toronto Ontario

M9L 1T9 Canada

Pemegang Pendaftaran Produk

Pharmaforte (M) Sdn Bhd

2, Jalan PJU 3/49

Sunway Damansara

47810 Petaling Jaya

Tarikh Kemaskini RiMUP

4/12/2014

No siri

BPFK(R4/1)031214/00069

13-3-2019

Pest categorisation of Phymatotrichopsis omnivora

Pest categorisation of Phymatotrichopsis omnivora

Published on: Tue, 12 Mar 2019 The Panel on Plant Health performed a pest categorisation of Phymatotrichopsis omnivora, the causal agent of Phymatotrichum root rot of more than 2,000 dicotyledonous plant species, for the EU. The pest is listed as Trechispora brinkmannii in Annex IAI of Directive 2000/29/EC. P. omnivora is a well‐defined fungal species and reliable methods exist for its detection and identification. It is present in south‐western USA, northern Mexico, Libya and Venezuela. The pest is not...

Europe - EFSA - European Food Safety Authority EFSA Journal

7-3-2019

Pest survey card on Popillia japonica

Pest survey card on Popillia japonica

Published on: Wed, 06 Mar 2019 This pest survey card was prepared in the context of the mandate on plant pest surveillance (EFSA‐Q‐2017‐00831), upon request by the European Commission. The purpose of this document is to assist the Member States in planning annual survey activities of quarantine organisms using a statistically sound and risk‐based pest survey approach, in line with the current international standards. The data requirements for such activity include the pest distribution, its host range, ...

Europe - EFSA - European Food Safety Authority EFSA Journal

7-3-2019

Safety and efficacy of Robenz® 66G (robenidine hydrochloride) for chickens for fattening and turkeys for fattening

Safety and efficacy of Robenz® 66G (robenidine hydrochloride) for chickens for fattening and turkeys for fattening

Published on: Tue, 05 Mar 2019 Following a request from European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of Robenz® 66G (robenidine hydrochloride (HCl)) when used as a feed additive for chickens for fattening and turkeys for fattening. The coccidiostat Robenz®66G is considered safe for chickens for fattening at the highest proposed level of 36 mg robenidine HCl/kg complete feed with a ...

Europe - EFSA - European Food Safety Authority EFSA Journal

5-3-2019

Safety and efficacy of Beltherm MP/ML (endo-1,4-betaxylanase) as a feed additive for piglets, pigs for fattening and other porcine species

Safety and efficacy of Beltherm MP/ML (endo-1,4-betaxylanase) as a feed additive for piglets, pigs for fattening and other porcine species

Published on: Mon, 04 Mar 2019 Beltherm MP/ML contains endo-1,4-beta-xylanase and it is to be used as a zootechnical additive for weaned piglets, pigs for fattening and minor porcine species for fattening. The safety and efficacy of the additive when used for poultry species have been evaluated previously by the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel). In that assessment, the safety for the consumers, environment and the users was assessed. The applicant has ...

Europe - EFSA - European Food Safety Authority EFSA Journal

5-3-2019

Safety and efficacy of Beltherm MP/ML (endo‐1,4‐beta‐xylanase) as a feed additive for chickens for fattening, chickens reared for laying, turkeys for fattening, turkeys reared for breeding, turkeys for breeding purposes and minor poultry species

Safety and efficacy of Beltherm MP/ML (endo‐1,4‐beta‐xylanase) as a feed additive for chickens for fattening, chickens reared for laying, turkeys for fattening, turkeys reared for breeding, turkeys for breeding purposes and minor poultry species

Published on: Fri, 01 Mar 2019 Beltherm MP/ML contains endo‐1,4‐beta‐xylanase and is intended to be used as a zootechnical additive for poultry species. The safety and efficacy of the additive have been evaluated by the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel) in 2017. In that assessment, the additive and the production strain, a genetically modified strain of Bacillus subtilis, were characterised in full. No viable cells of the production strain were detecte...

Europe - EFSA - European Food Safety Authority EFSA Journal

5-3-2019

Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) for all poultry species

Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) for all poultry species

Published on: Fri, 01 Mar 2019 The additive Calsporin® is a preparation of viable spores of Bacillus subtilis DSM 15544, at a minimum declared concentration of 1 × 1010 colony forming units (CFU)/g additive. The additive is authorised as a zootechnical additive (functional group: gut flora stabiliser) for use in chickens for fattening, weaned piglets, chickens reared for laying, turkeys, minor avian species and other ornamental and game birds, laying hens and ornamental fish, dogs, in sows and in suckli...

Europe - EFSA - European Food Safety Authority EFSA Journal

26-2-2019

Safety and efficacy of TYFER™ (ferric tyrosine chelate) as a zootechnical feed additive for chickens, turkeys and minor poultry species for fattening or reared for laying/breading

Safety and efficacy of TYFER™ (ferric tyrosine chelate) as a zootechnical feed additive for chickens, turkeys and minor poultry species for fattening or reared for laying/breading

Published on: Mon, 25 Feb 2019 Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of the product TYFER™ (ferric tyrosine chelate) as zootechnical feed additive for chickens, turkeys and minor poultry species for fattening or reared for laying/breeding. The additive is safe for chickens for fattening at the maximum expected level of 200 mg TYFER™/kg complete feed; this conclusion can be extended to chickens reared for laying/breedin...

Europe - EFSA - European Food Safety Authority EFSA Journal

16-1-2019

Safety and efficacy of B‐Act® (Bacillus licheniformis DSM 28710) as a feed additive for turkeys for fattening, turkeys reared for breeding and minor poultry species for fattening or raised for laying

Safety and efficacy of B‐Act® (Bacillus licheniformis DSM 28710) as a feed additive for turkeys for fattening, turkeys reared for breeding and minor poultry species for fattening or raised for laying

Published on: Mon, 14 Jan 2019 Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed was asked to deliver a scientific opinion on the safety and efficacy of B‐Act® when used in feed for turkeys for fattening, reared for breeding and minor poultry species for fattening or raised for laying. B‐Act® is a preparation containing viable spores of a Bacillus licheniformis strain. This species is considered by EFSA to be suitable for the qua...

Europe - EFSA - European Food Safety Authority EFSA Journal

16-1-2019

Voluntary Recall Notice of El Guapo Chile Habanero and Chile Pasilla-Ancho Pouches Due to Unlabeled Peanut Allergen

Voluntary Recall Notice of El Guapo Chile Habanero and Chile Pasilla-Ancho Pouches Due to Unlabeled Peanut Allergen

Mojave Foods Corporation is initiating a voluntary recall of El Guapo Chile Habanero and Chile Pasilla-Ancho pouches due to an unlabeled peanut allergen.

FDA - U.S. Food and Drug Administration

18-12-2018

Apo-Prednisone 5 mg Tablet (2018-12-18)

Apo-Prednisone 5 mg Tablet (2018-12-18)

Health Canada

11-12-2018

International Lubricants, Inc. recalls Kool-It Evaporator & Heater Foam Cleaner

International Lubricants, Inc. recalls Kool-It Evaporator & Heater Foam Cleaner

The recalled product does not have proper consumer chemical hazard labelling as required by the Consumer Chemicals and Containers Regulations, 2001 under the Canada Consumer Product Safety Act.

Health Canada

27-11-2018

Database of processing techniques and processing factors compatible with the EFSA food classification and description system FoodEx 2 Objective 1: Compendium of Representative Processing Techniques investigated in regulatory studies for pesticides

Database of processing techniques and processing factors compatible with the EFSA food classification and description system FoodEx 2 Objective 1: Compendium of Representative Processing Techniques investigated in regulatory studies for pesticides

Published on: Mon, 26 Nov 2018 EFSA is conducting pan‐European dietary exposure and risk assessments related to actual levels of pesticide residues in food commodities. These assessments use the pesticide occurrence data generated under the official monitoring programs of Member States, the consumption data from EFSA's comprehensive food consumption database and pesticide‐specific information such as processing factors. Currently no harmonised list of processing factors is available within Europe and wo...

Europe - EFSA - European Food Safety Authority Publications

13-11-2018

Setting of import tolerances for teflubenzuron in grapefruits, mandarins and broccoli

Setting of import tolerances for teflubenzuron in grapefruits, mandarins and broccoli

Published on: Mon, 12 Nov 2018 00:00:00 +0100 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant BASF Agro BV submitted a request to the competent national authority in the United Kingdom to set import tolerances for the active substance teflubenzuron in grapefruits and mandarins imported from Brazil and for broccoli imported from Paraguay. The data submitted were found to be sufficient to derive maximum residue level (MRL) proposals for grapefruits and broccoli. The MRL derived ...

Europe - EFSA - European Food Safety Authority Publications

10-11-2018

Pest categorisation of Popillia japonica

Pest categorisation of Popillia japonica

Published on: Thu, 08 Nov 2018 00:00:00 +0100 The Panel on Plant Health performed a pest categorisation of Popillia japonica(Coleoptera: Scarabaeidae) for the EU. P. japonica is a distinguishable species listed in Annex IAII of Council Directive 2000/29/EC. It is native to Japan but established in the USA in the early 20th century. It spreads from New Jersey to most US states east of the Mississippi, some to the west and north into Canada. P. japonica feeds on over 700 plant species. Adults attack folia...

Europe - EFSA - European Food Safety Authority Publications

7-8-2018

Voluntary Recall Notice of El Guapo Jamaica Hibiscus Flower Pouches Due to Unlabeled Peanut Allergen

Voluntary Recall Notice of El Guapo Jamaica Hibiscus Flower Pouches Due to Unlabeled Peanut Allergen

Mojave Foods Corporation is initiating a voluntary recall of four sizes of El Guapo Jamaica Hibiscus Flower packages in flexible packaging due to an unlabeled peanut allergen

FDA - U.S. Food and Drug Administration

9-6-2018

Caito Foods, LLC Voluntarily Recalls Fresh Cut Melon Products Because of Possible Health Risk

Caito Foods, LLC Voluntarily Recalls Fresh Cut Melon Products Because of Possible Health Risk

Caito Foods is voluntarily recalling fresh cut watermelon, honeydew melon, cantaloupe and fresh-cut mixed fruit containing one of these melons, produced at the Caito Foods facility in Indianapolis, because these products have the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

29-1-2019


Opinion/decision on a Paediatric investigation plan (PIP): atorvastatin (calcium trihydrate),Perindopril (arginine),indapamide, decision type: , therapeutic area: , PIP number: P/0333/2018

Opinion/decision on a Paediatric investigation plan (PIP): atorvastatin (calcium trihydrate),Perindopril (arginine),indapamide, decision type: , therapeutic area: , PIP number: P/0333/2018

Opinion/decision on a Paediatric investigation plan (PIP): atorvastatin (calcium trihydrate),Perindopril (arginine),indapamide, decision type: , therapeutic area: , PIP number: P/0333/2018

Europe - EMA - European Medicines Agency

18-1-2019


Opinion/decision on a Paediatric investigation plan (PIP): Acetylsalicylic acid / rosuvastatin (calcium) / perindopril (tert-butylamine) / indapamide (hemihydrate), decision type: , therapeutic area: , PIP number: P/0311/2018

Opinion/decision on a Paediatric investigation plan (PIP): Acetylsalicylic acid / rosuvastatin (calcium) / perindopril (tert-butylamine) / indapamide (hemihydrate), decision type: , therapeutic area: , PIP number: P/0311/2018

Opinion/decision on a Paediatric investigation plan (PIP): Acetylsalicylic acid / rosuvastatin (calcium) / perindopril (tert-butylamine) / indapamide (hemihydrate), decision type: , therapeutic area: , PIP number: P/0311/2018

Europe - EMA - European Medicines Agency

18-12-2018

APO-Valsartan (valsartan) tablets

APO-Valsartan (valsartan) tablets

Recall - potential contamination

Therapeutic Goods Administration - Australia